CLASS II ONGOING Drug recall · Reported 18 Feb 2026 · FDA Enforcement Report
5% Lidocaine, [ or] recalled by Pro Numb Tattoo Numbing Spray
Pro Numb Tattoo Numbing Spray is recalling 5% Lidocaine, [ or] per, distributed nationwide in the US. The recall was initiated on 2 Feb 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0302-2026
- FDA event ID
- 98361
- Recalling firm
- Pro Numb Tattoo Numbing Spray, Palm Bay, FL
- Brand
- Pro Numb
- Manufacturer
- Pro Numb Tattoo Numbing Spray LLC
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 2 Feb 2026
- FDA classified
- 9 Feb 2026
- Reported
- 18 Feb 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Pain Medication
Timeline
| 2 Feb 2026 | Recall initiated by company | |
| 9 Feb 2026 | Classified by FDA | +7 days |
| 18 Feb 2026 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP deviations
Product as listed by the FDA
Pro Numb Tattoo Numbing Spray, 5% Lidocaine, [1 FL OZ/28.4 ML or 4 oz/120 mL] per bottle, Distributed by: Pro Numb Tattoo numbing spray LLC, Melbourne, FL 32907, NDC 83389-111-11
Where it was distributed
Nationwide in the USA
Questions about this recall
Why was it recalled?
cGMP deviations
Which lots are affected?
Lot Numbers J01 through J14, J55 through J69
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 98361| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | For Sensitive Skin, 4% Lidocaine, [ or] recalledPro Numb Sensitive Skin | Pro Numb Tattoo Numbing Spray | Manufacturing (CGMP) Deviations | Nationwide |
More recalls from Pro Numb Tattoo Numbing Spray
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | For Sensitive Skin, 4% Lidocaine, [ or] recalledPro Numb Sensitive Skin | Pro Numb Tattoo Numbing Spray | Manufacturing (CGMP) Deviations | Nationwide |